Loading, Please Wait...
AUSTIN, Texas, March 05, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that management will provide a corporate overview at the Cowen & Company 39th Annual Health Care Conference, and the Oppenheimer & Co., 29th Annual Health Care Conference.
|Cowen & Company 39 th Annual Health Care Conference|
|Date:||Monday, March 11|
|Time:||3:30pm Eastern Time|
|Oppenheimer & Co 29 th Annual Health Care Conference|
|Date:||Tuesday, March 19|
|Time:||8:00am Eastern Time|
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates’ website at www.mtem.com.
Chief Financial Officer
Source: Molecular Templates, Inc.